Prils Market Research Report Information by Type (Ramipril, Quinapril, Cilazapril, & Benazepril), Application (Hypertension, Heart Failure, & Chronic Kidney Disorders), & Region (Americas, Europe, Asia-Pacific & the Middle East & Africa) - Global Forecast till 2032

1 Executive Summary

2 Market Introduction

2.1 Scope of the Study 13

2.2 Research Objective 13

2.3 List of Assumptions 14

3 Research Methodology

3.1 Research Process 15

3.2 Primary Research 16

3.3 Secondary Research 17

3.4 Market Size Estimation 18

4 Market Dynamics

4.1 Introduction 19

4.2 Drivers 20

4.2.1 Growing Pharmaceutical Industry 20

4.2.2 Growing Prevalence of Chronic Diseases Across the World 20

4.2.3 Growing Importance of Generic Drugs 20

4.3 Restraints 21

4.3.1 Stringent Regulatory Policies 21

4.3.2 Adverse Drug Price Control Policies Across Numerous Countries 21

4.4 Opportunity 22

4.4.1 Development of New Drugs 22

4.5 Product Pipeline Analysis 22

4.5.1 Introduction 22

4.5.2 NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients 23

4.5.3 Testing Ramipril to Prevent Memory Loss in People with Glioblastoma 23

4.5.4 Ramipril Treatment of Claudication 24

4.5.5 Bariatric Surgery and Pharmacokinetics of Ramipril 24

5 Market Factor Analysis

5.1 Value Chain Analysis 25

5.1.1 R&D and Designing 25

5.1.2 Manufacturing 25

5.1.3 Distribution & Sales 25

5.1.4 Marketing & Sales 26

5.1.5 Post-Sales Review 26

5.2 Porter’s Five Forces Model 26

5.2.1 Bargaining Power of Suppliers 28

5.2.2 Bargaining Power of Buyers 28

5.2.3 Threat of New Entrants 28

5.2.5 Intense Rivalry 28

5.3 Specifications & Purity Requirements 29

5.4 Patent Analysis 30

5.4.1 Introduction 30

5.5 Regulatory Analysis 31

6 Prils Market, by Type

6.1 Introduction 32

6.2 Ramapril 34

6.3 Quinapril 34

6.4 Cilazapril 35

6.5 Benazepril 35

7 Prils Market, by Application

7.1 Introduction 36

7.2 Hypertension 37

7.3 Heart Failure 38

7.4 Chronic Kidney Disorders 38

8 Global Prils Market, by Region

8.1 Introduction 39

8.2 Americas 41

Prils Market, by Type

Prils Market, by Application

8.2.1 North America 43

Prils Market, by Type

Prils Market, by Application

8.2.1.1 US 44

Prils Market, by Type

Prils Market, by Application

8.2.1.2 Canada 45

Prils Market, by Type

Prils Market, by Application

8.2.2 South America 46

Prils Market, by Type

Prils Market, by Application

8.3 Europe 48

Prils Market, by Type

Prils Market, by Application

8.3.1 Western Europe 50

Prils Market, by Type

Prils Market, by Application

8.3.1.1 Germany 52

Prils Market, by Type

Prils Market, by Application

8.3.1.2 UK 53

Prils Market, by Type

Prils Market, by Application

8.3.1.3 France 54

Prils Market, by Type

Prils Market, by Application

8.3.1.4 Italy 55

Prils Market, by Type

Prils Market, by Application

8.3.1.5 Spain 56

Prils Market, by Type

Prils Market, by Application

8.3.1.6 Rest of Western Europe 57

Prils Market, by Type

Prils Market, by Application

8.3.1.7 Eastern Europe 58

Prils Market, by Type

Prils Market, by Application

8.4 Asia-Pacific 59

Prils Market, by Type

Prils Market, by Application

8.4.1 Japan 61

Prils Market, by Type

Prils Market, by Application

8.4.2 China 62

Prils Market, by Type

Prils Market, by Application

8.4.3 India 63

Prils Market, by Type

Prils Market, by Application

8.4.4 Australia 64

Prils Market, by Type

Prils Market, by Application

8.4.5 South Korea 65

Prils Market, by Type

Prils Market, by Application

8.4.6 Rest of Asia-Pacific 66

Prils Market, by Type

Prils Market, by Application

8.5 Middle East & Africa 68

Prils Market, by Type

Prils Market, by Application

8.5.1 Middle East 70

Prils Market, by Type

Prils Market, by Application

8.5.2 Africa 71

Prils Market, by Type

Prils Market, by Application

9 Competitive landscape

9.1 Introduction 72

9.2 Key developments 72

10 Company Profiles

10.1 Aurobindo Pharma 75

10.1.1 Company Overview 75

10.1.2 Financial Overview 75

10.1.3 Products/Services Offered 76

10.1.4 Key Developments 76

10.1.5 SWOT Analysis 76

10.1.6 Key Strategies 77

10.2 Lupin 78

10.2.1 Company Overview 78

10.2.2 Financial Overview 78

10.2.3 Products/Services Offered 79

10.2.4 Key Developments 79

10.2.5 SWOT Analysis 79

10.2.6 Key Strategies 80

10.3 Pfizer, Inc. 81

10.3.1 Company Overview 81

10.3.2 Financial Overview 81

10.3.3 Products/Services Offered 82

10.3.4 Key Developments 82

10.3.5 SWOT Analysis 82

10.3.6 Key Strategies 83

10.4 Mylan N.V. 84

10.4.1 Company Overview 84

10.4.2 Financial Overview 84

10.4.3 Products/Services Offered 85

10.4.4 Key Developments 85

10.4.5 SWOT Analysis 85

10.4.6 Key Strategies 86

10.5 F. Hoffmann-La Roche 87

10.5.1 Company Overview 87

10.5.2 Financial Overview 87

10.5.3 Products/Services Offered 88

10.5.4 Key Developments 88

10.5.5 SWOT Analysis 88

10.5.6 Key Strategies 88

10.6 Sun Pharmaceutical Industries Ltd 89

10.6.1 Company Overview 89

10.6.2 Financial Overview 89

10.6.3 Products/Services Offered 90

10.6.4 Key Developments 90

10.6.5 SWOT Analysis 90

10.6.6 Key Strategies 90

10.7 Merck KGaA 91

10.7.1 Company Overview 91

10.7.2 Financial Overview 91

10.7.3 Products/Services Offered 92

10.7.4 Key Developments 92

10.7.5 SWOT Analysis 92

10.7.6 Key Strategies 92

10.8 Manus Aktteva Biopharma LLP 93

10.8.1 Company Overview 93

10.8.2 Financial Overview 93

10.8.3 Products/Services Offered 93

10.8.4 Key Developments 93

10.8.5 SWOT Analysis 94

10.8.6 Key Strategies 94

10.9 Canagen Pharmaceuticals Inc. 95

10.9.1 Company Overview 95

10.9.2 Financial Overview 95

10.9.3 Products/Services Offered 95

10.9.4 Key Developments 95

10.9.5 SWOT Analysis 96

10.9.6 Key Strategies 96

10.10 Novartis AG 97

10.10.1 Company Overview 97

10.10.2 Financial Overview 97

10.10.3 Products/Services Offered 98

10.10.4 Key Developments 98

10.10.5 SWOT Analysis 98

10.10.6 Key Strategies 98

11 Appendix

References 99

Related Reports 99

12 List of Tables

TABLE 1 LIST OF ASSUMPTIONS 14

TABLE 2 PRIMARY INTERVIEWS 16

TABLE 3 PRILS MARKET: PRODUCT PIPELINE ANALYSIS 22

TABLE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PRILS MARKET 26

TABLE 5 PATENT ANALYSIS FOR GLOBAL PRILS MARKET 30

TABLE 6 GLOBAL PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 32

TABLE 7 GLOBAL PRILS MARKET, BY TYPE, 2020 TO 2027 (VOLUME PER UNIT) 33

TABLE 8 GLOBAL PRILS MARKET, BY TYPE, 2020 TO 2027 (ASP {USD} PER UINT) 33

TABLE 9 GLOBAL PRILS MARKET, FOR RAMAPRIL, BY REGION, 2020 TO 2027 (USD MILLION) 34

TABLE 10 GLOBAL PRILS MARKET, FOR QUINAPRIL, BY REGION, 2020 TO 2027 (USD MILLION) 34

TABLE 11 GLOBAL PRILS MARKET, FOR CILAZAPRIL, BY REGION, 2020 TO 2027 (USD MILLION) 35

TABLE 12 GLOBAL PRILS MARKET, FOR BENAZEPRIL, BY REGION, 2020 TO 2027 (USD MILLION) 35

TABLE 13 GLOBAL PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 36

TABLE 14 GLOBAL PRILS MARKET, FOR HYPERTENSION, BY REGION, 2020 TO 2027 (USD MILLION) 37

TABLE 15 GLOBAL PRILS MARKET, FOR HEART FAILURE, BY REGION, 2020 TO 2027 (USD MILLION) 38

TABLE 16 GLOBAL PRILS MARKET, FOR CHRONIC KIDNEY DISORDERS, BY REGION, 2020 TO 2027 (USD MILLION) 38

TABLE 17 GLOBAL PRILS MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 39

TABLE 18 AMERICAS: PRILS MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 41

TABLE 19 AMERICAS: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 41

TABLE 20 AMERICAS: PRILS MARKET, BY TYPE, 2020 TO 2027 (VOLUME PER UNIT) 42

TABLE 21 AMERICAS: PRILS MARKET, BY TYPE, 2020 TO 2027 (ASP {USD}PER UNIT) 42

TABLE 22 AMERICAS: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 42

TABLE 23 NORTH AMERICA: PRILS MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 43

TABLE 24 NORTH AMERICA: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 43

TABLE 25 NORTH AMERICA: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 44

TABLE 26 US: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 44

TABLE 27 US: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 45

TABLE 28 CANADA: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 45

TABLE 29 CANADA: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 46

TABLE 30 SOUTH AMERICA: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 46

TABLE 31 SOUTH AMERICA: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 47

TABLE 32 EUROPE: PRILS MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 48

TABLE 33 EUROPE: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 48

TABLE 34 EUROPE: PRILS MARKET, BY TYPE, 2020 TO 2027 (VOLUME PER UNIT) 49

TABLE 35 EUROPE: PRILS MARKET, BY TYPE, 2020 TO 2027 (ASP{USD} PER UNIT) 49

TABLE 36 EUROPE: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 49

TABLE 37 WESTERN EUROPE: PRILS MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 50

TABLE 38 WESTERN EUROPE: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 51

TABLE 39 WESTERN EUROPE: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 51

TABLE 40 GERMANY: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 52

TABLE 41 GERMANY: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 52

TABLE 42 UK: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 53

TABLE 43 UK: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 53

TABLE 44 FRANCE: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 54

TABLE 45 FRANCE: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 54

TABLE 46 ITALY: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 55

TABLE 47 ITALY: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 55

TABLE 48 SPAIN: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 56

TABLE 49 SPAIN: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 56

TABLE 50 REST OF WESTERN EUROPE: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 57

TABLE 51 REST OF WESTERN EUROPE: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 57

TABLE 52 EASTERN EUROPE: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 58

TABLE 53 EASTERN EUROPE: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 58

TABLE 54 ASIA-PACIFIC: PRILS MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 59

TABLE 55 ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 60

TABLE 56 ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2020 TO 2027 (VOLUME PER UNIT) 60

TABLE 57 ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2020 TO 2027 (ASP{USD} PER UNIT) 60

TABLE 58 ASIA-PACIFIC: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 61

TABLE 59 JAPAN: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 61

TABLE 60 JAPAN: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 62

TABLE 61 CHINA: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 62

TABLE 62 CHINA: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 63

TABLE 63 INDIA: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 63

TABLE 64 INDIA: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 64

TABLE 65 AUSTRALIA: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 64

TABLE 66 AUSTRALIA: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 65

TABLE 67 SOUTH KOREA: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 65

TABLE 68 SOUTH KOREA: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 66

TABLE 69 REST OF ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 66

TABLE 70 REST OF ASIA-PACIFIC: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 67

TABLE 71 MIDDLE EAST & AFRICA: PRILS MARKET, BY REGION, 2020 TO 2027 (USD MILLION) 68

TABLE 72 MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 68

TABLE 73 MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE, 2020 TO 2027 (VOLUME PER UNIT) 69

MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE, 2020 TO 2027 (ASP{USD} PER UNIT) 69

TABLE 74 MIDDLE EAST & AFRICA: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 69

TABLE 75 MIDDLE EAST: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 70

TABLE 76 MIDDLE EAST: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 70

TABLE 77 AFRICA: PRILS MARKET, BY TYPE, 2020 TO 2027 (USD MILLION) 71

TABLE 78 AFRICA: PRILS MARKET, BY APPLICATION, 2020 TO 2027 (USD MILLION) 71

TABLE 79 MAJOR MANUFACTURERS IN THE GLOBAL PRILS MARKETMARKET 72

TABLE 80 KEY DEVELOPMENTS BY PLAYERS IN THE MARKET 73

13 List of Figures

FIGURE 1 MARKET SYNOPSIS 12

FIGURE 2 GLOBAL PRILS MARKET: STRUCTURE 14

FIGURE 3 RESEARCH PROCESS 15

FIGURE 4 TOP-DOWN AND BOTTOM-UP APPROACHES 18

FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PRILS MARKET 19

FIGURE 6 VALUE CHAIN: GLOBAL PRILS MARKET 25

FIGURE 7 GLOBAL PRILS MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 33

FIGURE 8 GLOBAL PRILS MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 37

FIGURE 9 GLOBAL PRILS MARKET SHARE, BY REGION, 2020 (%) 40

FIGURE 10 AMERICAS: PRILS MARKET SHARE, BY REGION, 2020 (%) 41

FIGURE 11 NORTH AMERICA: PRILS MARKET SHARE, BY REGION, 2020 (%) 43

FIGURE 12 EUROPE: PRILS MARKET SHARE, BY REGION, 2020 (%) 48

FIGURE 13 WESTERN EUROPE: PRILS MARKET SHARE, BY REGION, 2020 (%) 50

FIGURE 14 ASIA-PACIFIC: PRILS MARKET SHARE, BY REGION, 2020 (%) 59

FIGURE 15 MIDDLE EAST & AFRICA: PRILS MARKET SHARE, BY REGION, 2020 (%) 68

FIGURE 1 CATEGORY WISE SHARE OF KEY DEVELOPMENTS 74